Cargando…
Could Early Identification of Changes in Olfactory Function Be an Indicator of Preclinical Neurodegenerative Disease? A Systematic Review
INTRODUCTION: Alzheimer’s disease (AD) is a debilitating neurodegenerative disease that currently affects 850,000 individuals in the UK with estimates continuing to rise. Diagnosis is only available in the presence of significant neuronal pathology and apparent cognitive decline, meaning that treatm...
Autores principales: | Winchester, Rikki L., Martyn, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606376/ https://www.ncbi.nlm.nih.gov/pubmed/32529479 http://dx.doi.org/10.1007/s40120-020-00199-z |
Ejemplares similares
-
Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders
por: Rebholz, Heike, et al.
Publicado: (2020) -
The basics of preclinical drug development for neurodegenerative disease indications
por: Steinmetz, Karen L, et al.
Publicado: (2009) -
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment
por: Fatuzzo, Irene, et al.
Publicado: (2023) -
Preclinical progression of neurodegenerative diseases
por: Katsuno, Masahisa, et al.
Publicado: (2018) -
Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction
por: Markopoulou, Katerina, et al.
Publicado: (2016)